Techpool Bio-pharma Co., Ltd. Company Profile

News Articles [ 1179 Associated News Articles listed on BioPortfolio]

Techpool In-Licenses China Rights to Bone Cancer Drug from Roche

Guangzhou Techpool Bio-Pharma in-licensed the China rights to Bondronat, an oncology drug from Roche. Bondronat is a treatment for metastatic bone cancer. It treats pain along with fractures, spine co...

Roche and Takeda’s Techpool to maximize Bondronat in China

Roche has signed a contract with Takeda subsidiary Techpool Bio that will allow the Chinese pharma company exclusively to market the Swiss firm's oral bisphosphonate drug for bone metastases Bondrona...

Roche Grants First Drug License In China, To Takeda-Owned Drug Maker

For the first time, Roche has licensed one of its drugs, Boniva (ibandronate), a chemotherapy drug for treating cancer cells, to a China-based company, albeit it Techpool Bio-Pharma.

Roche Grants First Drug License In China To Takeda-Owned Drug Maker

For the first time, Roche has licensed one of its drugs, Boniva (ibandronate), to a China-based company, Techpool Bio-Pharma, which is owned by Takeda.

Week in Review: WuXi PharmaTech and PRA Form Clinical CRO JV

WuXi PharmaTech is forming a JV with PRA, a US-based clinical-stage CRO, that will offer Phase I-IV clinical trial services in China; ShangPharma agreed to a go-private offer from its Founder and TPG...

Pharma 3.0 Pulls Companies into the Digital Future

Social media and mobile marketing have kick-started the pharma industry into a phase dubbed Pharma 3.0.  Gone are the days of Pharma 1.0 in which companies could rely on a handful of blockbuster drug...

Big pharma companies BMS and Merck are pharma partnering on Daclatasvir

Big pharma company, Bristol-Myers Squibb, is pharma partnering with another big pharma company, Merck, to develop Daclatasvir to treat Hepatitis C. The big pharma companies will work on the hepatitis...

Merck enter pharma partnering pact with Ra Pharma for cyclomimetics

Ra Pharmaceuticals has entered into a pharma partnering deal with Merck, a top 50 big pharma corporation, focused on the development of Cyclomimetics, a new class of compounds that have the diversity...

Drugs and Medications [ 238 Associated Drugs and Medications listed on BioPortfolio]

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 0.5 mg

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 1 mg

Metoprolol tartrate [Med-Health Pharma, LLC]

Metoprolol Tartrate Tablets, USP

Urea [Libertas Pharma, Inc.]

Rx Only 45% Urea Nail Gel In a vehicle containing Camphor, Eucalyptus Oil and Menthol )

Eloxatin [Aventis Pharma Ltd.]

PubMed Articles [ 56 Associated PubMed Articles listed on BioPortfolio]

Comment about the article "Psychopharmaceuticals and diabetes" of Ress C, Tschoner A, Kaser S, and Ebenbichler CF in Wiener Medizinische Wochenschrift 2011; 161/21-22: 531-42.

Discovery of new chemotype dipeptidyl peptidase IV inhibitors having (R)-3-amino-3-methyl piperidine as a pharmacophore.

Structures containing the (R)-3-amino-3-methyl piperidine unit as a new pharmacophore moiety have been shown to possess moderate inhibitory activity for DPP-4 with good pharmacokinetics profile. One o...

Is pharma running out of brainy ideas?

Big pharma moves from 'blockbusters' to 'niche busters'.

China spurs pharma innovation.

Clinical Trials [ 35 Associated Clinical Trials listed on BioPortfolio]

To Demonstrate the Relative Bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam Tablets In Healthy Adults Volunteers Under Fasting Conditions

To demonstrate the relative bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam tablets in healthy adult volunteers under fasting conditions.

Pharma-Pen (Formerly Innoject) Auto-Injectory TIV

The purpose of this study is to evaluate the safety, effectiveness, and tolerability, of the Pharma-Pen(TM) intramuscular (IM) and subcutaneous (SC) auto-injector systems used by untrained...

To Demonstrate the Relative Bioavailability of Cilostazol 50 mg Tablets Under Fasting Conditions

To demonstrate the relative bioavailability of Cilostazol 50 mg tablets under fasting conditions.

Safety and Efficacy of LCP-Tacro™ Once Daily in Stable Renal Transplant Patients Converted From Prograf® Twice Daily

This is 2-armed parallel group, prospective, randomized, open-label, multicenter Phase 3 controlled trial to establish the efficacy and safety of conversion from maintenance immunosuppress...

Development of a New Method for Analgesia

Aim: To examine a new method to perform local anesthesia in order to diminish the inconvenience by the procedure in patients before performing intubation or oesophagogastroduodenoscopy.

Companies [ 591 Associated Companies listed on BioPortfolio]

Techpool Bio-pharma Co., Ltd.

Established in 1993, Techpool Bio-Pharma Co., Ltd. is one of the leading bio-pharma companys in China, with total assets of USD30 million and registered capital of USD11.7 million. We are specializing...

H3 Pharma Incorporated

H3 Pharma Inc. is a Venture Pharma focusing on the development of human therapeutic products oriented towards age-related disorders. At H3 Pharma, we aim to be the best at identifying, evaluating and...

LEO Pharma Inc.

LEO Pharma Inc. is headquartered in Parsippany, New Jersey, and is the U.S. affiliate of Denmark-based LEO Pharma A/S, a global leader in dermatology and critical care with more t...

Laurantis Pharma Oy

Laurantis Pharma Oy is a privately held specialty pharmaceutical company based in Finland. Laurantis Pharma Oy was formed in 2010 through the merger of two independent companies,...

FranceMed Pharma

FranceMed Pharma is a Research, Development, FMCG Manufacturer and Global Marketing Company established since 1981. FranceMed Pharma owns Magicool® brand and the world-wide patents and technology. Fr...